The Company is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colorectal cancer diagnostic kits. The BCT kits are used for analyzing the expression level of the cancer-related gene. The products are sold under the name of GenesWell. The Company was founded on September 21, 2011. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on October 27, 2015. On 25 June 2020, delisted from KOREA NEW EXCHANGE(KONEX).
Headquarters
1-67 Ogyegongdan-Gil, Geumho-Eup
Yeongcheon; Gyeongsangbuk;
Contact Details: Purchase the Gencurix Inc. report to view the information.
Website: http://www.sgretech.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service